Notice of Intent to Award Sole Source - Technelite® Generators Mo99/Tc99m and Xenon 133 Gas
ID: W81K00-26-Q-AxxxType: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M MRC0 WESTJBSA FT SAM HOUSTON, TX, 78234-4504, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/workspace/contract/opp/f7b84aa3214343bfad5ec7a86d623904/view
Timeline
    Description

    The Department of Defense, specifically the U.S. Army Health Contracting Activity, intends to award a sole source contract to Lantheus Medical Imaging, Inc. for the procurement of Technelite® Generators Mo99/Tc99m and Xenon 133 Gas. This contract is essential for the compounding of various radiopharmaceuticals within the Nuclear Medicine Pharmacy at Brooke Army Medical Center, located at JBSA Fort Sam Houston, Texas. The goods are critical for medical applications, particularly in nuclear medicine, where they play a vital role in diagnostic imaging and treatment. The contract is expected to be awarded on or about January 1, 2026, and interested parties may direct inquiries to Patrick Thielemann at patrick.a.thielemann.civ@health.mil or Christopher Gregory at christopher.a.gregory11.civ@mail.mil.

    Point(s) of Contact
    Patrick Thielemann
    patrick.a.thielemann.civ@health.mil
    Christopher Gregory
    christopher.a.gregory11.civ@mail.mil
    Files
    No associated files provided.
    Similar Opportunities
    Radiopharmaceutical Pluvicto, Locametz, Lutathera and Netspot Injections
    Buyer not available
    The Defense Health Agency (DHA) is planning to award a sole source, firm fixed-price Blanket Purchase Agreement to Novartis Pharmaceuticals Corporation for the provision of radiopharmaceutical injections, specifically Pluvicto, Locametz, Lutathera, and Netspot, for use at the Nuclear Medicine Division of the Naval Medical Center San Diego and other Medical Treatment Facilities. These injections are critical for emergency treatments, and the contract will be executed under the NPC FSS Contract: 36F79720D0180, as Novartis is deemed the only source capable of fulfilling the government's requirements. The period of performance for this contract is set from January 5, 2026, to January 4, 2031, and while this notice does not solicit competitive proposals, interested vendors may submit capability statements by December 9, 2026, to contest the sole source determination. For further inquiries, vendors can contact CHA-ON Gordon at cha-on.p.gordon2.civ@health.mil or Tracy Robinson at tracy.m.robinson18.civ@health.mil.
    Radiopharmaceuticals for Temple Texas VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking a contractor to provide radiopharmaceuticals for the Olin E. Teague VA Medical Center in Temple, Texas, through a short-term contract lasting six months. This procurement is critical for the Nuclear Medicine Department, as the radiopharmaceuticals are essential for medical imaging and therapeutic treatments for various carcinomas, with a total estimated procurement cost of $445,000. The urgency of this requirement is underscored by the short shelf-life of the products, necessitating timely delivery to ensure continuous patient care for veterans. Interested vendors can contact Jeffrey Crysler at jeffrey.crysler@va.gov or by phone at 210-617-5300 for further details.
    6505--Positron Emission Tomography (PET) Radiopharmaceuticals for the Albany VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking qualified contractors to provide Positron Emission Tomography (PET) Radiopharmaceuticals for the Albany VA Medical Center. This procurement is structured as a five-year, firm fixed-price, Indefinite Delivery, Indefinite Requirements (IDIQ) contract, which includes a 12-month base period and four 12-month option periods. The required radiopharmaceuticals include F18 FDG Fluorodeoxyglucose, F18 NaF Sodium Fluoride, Pylarify (piflufolastat F18), Neuroceq (florbetaben F18), and Flyrcado (flurpiridaz F18), all essential for patient care in the Nuclear Medicine Department. Interested contractors must be licensed by the United States Nuclear Regulatory Commission (NRC) and the Food and Drug Administration (FDA) to manufacture and distribute these products in New York State, with responses due by 12:00 PM Eastern Standard Time on December 8, 2025. For further inquiries, contractors can contact Jonathan Kilgore, the Contracting Officer, at jonathan.kilgore@va.gov or by phone at 973-676-1000.
    J065--NOTICE of INTENT SOLE SOURCE GE MACLAB Service and Support
    Buyer not available
    The Department of Veterans Affairs, Network Contracting Office 21 (NCO 21), intends to award a Firm Fixed Price contract to GE Healthcare, INC for the maintenance and support of the GE Healthcare Combolab systems (Mac Lab System) at the Veterans Affairs Sierra Nevada Health Care System. The contract, effective January 1, 2026, will require the contractor to provide all necessary labor, transportation, parts, and expertise, ensuring compliance with various national and industry standards, including NFPA-99 and OSHA, while maintaining a commitment to 99% equipment uptime. Interested parties may express their interest by submitting a detailed description of their capabilities via email to Gary Christensen at gary.christensen@va.gov by December 12, 2025, at 10:00 AM Pacific Standard Time, referencing solicitation number 36C26126Q0190. The government reserves the right to determine whether to compete the proposed contract based on the responses received.
    J065--Bayer Medrad Injectors Full Service
    Buyer not available
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source Firm-Fixed-Price Contract to Novamed Corporation for the full service of Bayer Medrad Injectors. This contract, identified as 36C25724P0085, will provide essential services including onsite support by a Bayer certified field engineer, hardware system coverage, calibration, software updates, EPM certified part replacements, and comprehensive inspection and safety testing for various Bayer/Medrad models at the Dallas VA Medical Center. The procurement is being conducted under FAR 13.5, indicating the intent to negotiate with a single source due to the specialized nature of the services required. Interested parties may submit their capability information by December 12, 2025, at 10:00 A.M. CT, to Rafael Rodriguez at Rafael.Rodriguez2@va.gov, as the government may consider competitive procurement based on the responses received.
    Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment.
    Buyer not available
    The Department of Defense, specifically the Department of the Army, intends to award a sole source contract to Biomerieux, Inc. for the maintenance of government-owned BacT/ALERT 3D equipment. This procurement aims to ensure the continued operational readiness and reliability of critical medical diagnostic equipment, which plays a vital role in healthcare settings. The contract will be awarded as a firm-fixed-price agreement under the authority of FAR 13.106-1(b)(1), with the North American Industry Classification System (NAICS) code 811210, which pertains to Electronic and Precision Equipment Repair and Maintenance. Interested parties may direct inquiries to Bobby Etheridge at bobby.j.etheridge.civ@health.mil; however, this notice is not a request for competitive proposals, and no reimbursement will be provided for information submitted.
    6515--Illumena Neo radiopaque contrast delivery system VA Cincinnati Health Care System 539-26-1-043-0047
    Buyer not available
    The Department of Veterans Affairs, Network Contracting Office 10, is soliciting offers for the purchase of the Illumena Neo radiopaque contrast delivery system for the VA Cincinnati Health Care System. This procurement aims to replace and install two end-of-life systems that are critical for precise contrast injection during medical imaging, including the provision of pedestal units, installation, application training, and necessary supplies such as syringes and tubing. The acquisition is classified under NAICS code 334510 and is identified as a brand name justification due to the proprietary nature of the equipment. Responses to the solicitation, numbered 36C25026Q0150, are due by December 9, 2025, at 2:00 PM Eastern Time, and will be evaluated based on the Lowest Price Technically Acceptable methodology. Interested parties should contact Contracting Specialist Laura Poma at laura.poma@va.gov or by phone at 734-845-3523 for further information.
    Notice of Intent to Sole Source - Linear Radiation Monitors
    Buyer not available
    The Defense Threat Reduction Agency (DTRA) intends to award a sole source contract to Sensor Technology Engineering, LLC (STE) for the procurement of two Linear Radiation Monitors (Part No. TA400). These monitors are critical for radiation detection and monitoring, and STE is the sole provider of this specific equipment, which underscores its unique capabilities in this field. Interested parties have five days from the publication date of this notice to submit written evidence of their qualifications to provide similar monitors, as the government will consider whether to conduct a competitive procurement based on the responses received. For inquiries, interested vendors should contact Zun Lin at zun.z.lin.civ@mail.mil or by phone at 571-616-5828.
    Y90 SIR Spheres
    Buyer not available
    The Department of Veterans Affairs is seeking to procure Y-90 SIR Spheres microspheres for use in Selective Internal Radiation Therapy (SIRT) at the North Texas Medical Center in Dallas, Texas. This contract involves the purchase of five unit doses of Sie-Spheres Y90 resin microspheres, estimated at $17,750 per dose, to ensure the availability of this critical treatment for patients with liver tumors. The unique characteristics of these microspheres, provided solely by Sirtex Medical, are essential for delivering targeted radiation therapy, as they are designed to lodge in tumor arterioles while minimizing exposure to healthy tissue. Interested parties can contact Contract Specialist Robert Clark at robert.clark15@va.gov or by phone at 512-228-1088 for further details regarding this procurement, which is justified under FAR 13.106-1 and is expected to exceed the micro-purchase threshold but remain under the simplified acquisition threshold of $250,000.
    J065--AGFA Preventive Maintenance and Service Base 2 years Intent to Sole Source
    Buyer not available
    The Department of Veterans Affairs (VA) intends to award a sole-source contract to AGFA US Corp. for preventive maintenance and support services for the AGFA DR 400 Detector System at the Worcester Belmont Street Campus. The contract will cover a base year plus two option years, from January 1, 2026, to December 31, 2028, requiring annual preventive maintenance and service support as detailed in the attached Statement of Work. This procurement is critical as AGFA US Corp. is the only provider capable of delivering the specialized and proprietary services necessary to maintain compliance with FDA and cybersecurity requirements. Interested parties may submit documentation to demonstrate their qualifications by December 11, 2025, at 11:00 AM EST, with all inquiries directed to Contract Specialist Kim McCarthy at kim.mccarthy@va.gov.